Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Silo Pharma Inc.

    NASDAQ: SILO · Real-Time Price · USD
    0.59
    -0.01 (-2.32%)
    At close: Jun 18, 2025, 11:35 AM

    Silo Pharma Statistics

    Share Statistics

    Silo Pharma has 7.21M shares outstanding. The number of shares has increased by 21.64% in one year.

    Shares Outstanding

    n/a
    		 7.21M

    Shares Change (YoY)

    n/a
    		 21.64%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 4.96%

    Shares Floating

    n/a
    		 6.11M

    Failed to Deliver (FTD) Shares

    n/a
    		 44,775

    FTD / Avg. Volume

    n/a
    		 4.87%

    Short Selling Information

    The latest short interest is 253.94K, so 3.52% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 253.94K

    Short % of Shares Out

    n/a
    		 3.52%

    Short % of Float

    n/a
    		 3.62%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.75 and the forward PE ratio is null. Silo Pharma's PEG ratio is 0.89.

    PE Ratio

    n/a
    		 -0.75

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 45.43

    Forward PS

    n/a
    		 61.5

    PB Ratio

    n/a
    		 0.65

    P/FCF Ratio

    n/a
    		 -0.85

    PEG Ratio

    n/a
    		 0.89
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Silo Pharma.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 4.29, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 4.29

    Quick Ratio

    n/a
    		 4.29

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 -925.59

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $24,034

    Profits Per Employee

    n/a
    		 $-1,464,293.33

    Employee Count

    n/a
    		 3

    Asset Turnover

    n/a
    		 0.01

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -37.5% in the last 52 weeks. The beta is 1.52, so Silo Pharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.52

    52-Week Price Change

    n/a
    		 -37.5%

    50-Day Moving Average

    n/a
    		 0.76

    200-Day Moving Average

    n/a
    		 1.11

    Relative Strength Index (RSI)

    n/a
    		 47.82

    Average Volume (20 Days)

    n/a
    		 919,550

    Income Statement

    In the last 12 months, Silo Pharma had revenue of 72.1K and earned -4.39M in profits. Earnings per share was -1.19.

    Revenue

    n/a
    		 72.1K

    Gross Profit

    n/a
    		 66.26K

    Operating Income

    n/a
    		 -4.71M

    Net Income

    n/a
    		 -4.39M

    EBITDA

    n/a
    		 -4.38M

    EBIT

    n/a
    		 -4.39M

    Earnings Per Share (EPS)

    n/a
    		 -1.19
    Full Income Statement

    Balance Sheet

    The company has 3.91M in cash and 0 in debt, giving a net cash position of 3.91M.

    Cash & Cash Equivalents

    n/a
    		 3.91M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -15.26M

    Total Assets

    n/a
    		 295.81K

    Working Capital

    n/a
    		 4.42M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -3.83M and capital expenditures 0, giving a free cash flow of -3.83M.

    Operating Cash Flow

    n/a
    		 -3.83M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -3.83M

    FCF Per Share

    n/a
    		 -1.04
    Full Cash Flow Statement

    Margins

    Gross margin is 91.9%, with operating and profit margins of -6526.44% and -6092.59%.

    Gross Margin

    n/a
    		 91.9%

    Operating Margin

    n/a
    		 -6526.44%

    Pretax Margin

    n/a
    		 -6092.59%

    Profit Margin

    n/a
    		 -6092.59%

    EBITDA Margin

    n/a
    		 -6076.97%

    EBIT Margin

    n/a
    		 -6526.44%

    FCF Margin

    n/a
    		 -5317.35%

    Dividends & Yields

    SILO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for SILO.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Sep 19, 2022. It was a backward split with a ratio of 1:50.

    Last Split Date

    n/a
    		 Sep 19, 2022

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:50

    Scores

    Altman Z-Score

    n/a
    		 -109.81

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist